Wingerchuk, Dean M.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 4,649

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet

Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and Treatments

Cited by 3,239

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Cree, B. A. C., Bennett, J. L., Kim, H. J., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., Fujihara, K., Paul, F., Cutter, G. R., Marignier, R., et al. (2019) · The Lancet

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 756

The contemporary spectrum of multiple sclerosis misdiagnosis

Solomon, A. J., Bourdette, D. N., Cross, A. H., Applebee, A., Skidd, P. M., Howard, D. B., Spain, R. I., Cameron, M. H., Kim, E., Mass, M. K., et al. (2016) · Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 334

Treatment of neuromyelitis optica: review and recommendations

Kimbrough, D. J., Fujihara, K., Jacob, A., Lana-Peixoto, M. A., Isabel Leite, M., Levy, M., Marignier, R., Nakashima, I., Palace, J., de Seze, J., et al. (2012) · Multiple Sclerosis and Related Disorders

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 260

Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders

Flanagan, E. P., Weinshenker, B. G., Krecke, K. N., Lennon, V. A., Lucchinetti, C. F., McKeon, A., Wingerchuk, D. M., Shuster, E. A., Jiao, Y., Horta, E. S., et al. (2015) · JAMA Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 249

Epidemiology and natural history of multiple sclerosis: new insights

Kantarci, O., & Wingerchuk, D. (2006) · Current Opinion in Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 156

Autonomic symptom burden is associated with MS-related fatigue and quality of life

Cortez, M. M., Nagi Reddy, S. K., Goodman, B., Carter, J. L., & Wingerchuk, D. M. (2015) · Multiple Sclerosis and Related Disorders

Multiple Sclerosis Research StudiesCardiovascular Syncope and Autonomic Disorders

Cited by 59

“Idiopathic” Rapid-Eye-Movement (REM) Sleep Behavior Disorder Is Associated With Future Development of Neurodegenerative Diseases

Hickey, M. G., Demaerschalk, B. M., Caselli, R. J., Parish, J. M., & Wingerchuk, D. M. (2007) · The Neurologist

Parkinson's Disease Mechanisms and TreatmentsSleep and related disorders

Cited by 35

Treatment of Vascular Dementia and Vascular Cognitive Impairment

Demaerschalk, B. M., & Wingerchuk, D. M. (2007) · The Neurologist

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 27

Frequency of asymptomatic optic nerve enhancement in a large retrospective cohort of patients with aquaporin-4+ NMOSD

Shah, S. S., Morris, P., Buciuc, M., Tajfirouz, D., Wingerchuk, D. M., Weinshenker, B. G., Eggenberger, E. R., Di Nome, M., Pittock, S. J., Flanagan, E. P., et al. (2022) · Neurology

Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome

Cited by 26